Showing results (111-120 of 140) with videos related to
Sort By:
Pageof 14
Infection and Immunity|October 26, 1999
Consequence of Nramp1 deletion to Mycobacterium tuberculosis infection in miceR J North, R LaCourse, L Ryan, et al.Infection and Immunity|May 1, 1980
Increased toxicity of endotoxin for tumor-bearing mice and mice responding to bacterial pathogens: macrophage activation as a common denominatorM J Berendt, M F Newborg, R J NorthThe Journal of Experimental Medicine|September 1, 1981
Mechanisms of anti-tumor action of Corynebacterium parvum. II. Potentiated cytolytic T cell response and its tumor-induced suppressionC D Mills, R J North, E S DyeInfection and Immunity|March 1, 1983
Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasisJ O Hill, R J North, F M CollinsJournal of Immunology (Baltimore, Md. : 1950)|July 1, 1981
Immunologic consequences of antibiotic-induced abridgement of bacterial infection: effect on generation and loss of protective T cells and level of immunologic memoryR J North, P A Berche, M F NewborgTransplantation|January 1, 1993
Evidence inconsistent with a role for tumor necrosis factor in tumor allograft rejectionA L Rakhmilevich, R J North, E S DyeJournal of Interferon Research|December 1, 1991
A role for tumor necrosis factor in poly(I:C)-induced hemorrhagic necrosis and T-cell-dependent regression of a murine sarcomaR J North, P L Dunn, E A HavellJournal of General Microbiology|July 1, 1991
Chlamydia trachomatis major outer membrane protein epitopes expressed as fusions with LamB in an attenuated aro A strain of Salmonella typhimurium; their application as potential immunogensL J Hayes, J W Conlan, J S Everson, et al.The Journal of Experimental Medicine|December 1, 1978
The immunological basis of endotoxin-induced tumor regression. Requirement for T-cell-mediated immunityM J Berendt, R J North, D P KirsteinThe Journal of Experimental Medicine|December 1, 1978
The immunological basis of endotoxin-induced tumor regression. Requirement for a pre-existing state of concomitant anti-tumor immunityM J Berendt, R J North, D P KirsteinPageof 14